Next stop for Falling Walls winner: Berlin
Biomedical engineering doctoral student Kilean Lucas had three minutes and three slides to describe how nanomembranes could help diagnose cancer.
Creating the model human
Physicians at the University of Rochester Medical Center have developed a new way to use 3D printing to fabricate artificial organs and human anatomy that mimics the real thing, even up to the point of bleeding when cut. These models are able to create highly realistic simulations for training and could soon be widely used to rehearse complex cases prior to surgery.
First worldwide trial tests defibrillators in diabetes patients
Individuals with diabetes have a high incidence of heart problems. A Medical Center study will determine if implantable defibrillators increase survival in this growing group of patients.
Tibet sediments reveal climate patterns from millions of years ago
The Tibetan Plateau in China experiences some of the most extreme weather patterns on Earth, making it an ideal location for Rochester climate scientists to student the complex web of global climate patterns.
A new way to teach history in the 21st century
A “virtual” re-creation of early settlements on Smith’s Island, Bermuda, offers professor Michael Jarvis and his students immersive experience of the site they are working to excavate.
Big library, big data
“Libraries have been managing data for centuries,” says Marcy Strong, head of metadata service at River Campus Libraries. And in the new field of data science, practitioners will rely on work University librarians have long done.
Medical Center plays key role in new Huntington’s drug
Medical Center researchers were instrumental in the U.S. Food and Drug Administration’s recent approval of SD-809 (deutetrabenazine) to treat Huntington’s disease.
Unlocking the secrets of blue notes
In the musical realm, notes “between the cracks” of conventional pitches are called blue notes. Researchers at Rochester are using advanced tools of music technology to unlock the secrets of blue notes.
FDA approves new eczema drug tested at URMC
The new drug, Dupilumab, is the first treatment to show significant, lasting results for adults with eczema. The FDA approval is a “game-changer,” says Lisa Beck, professor of dermatology who led three years of clinical trials.
Partnership will help create ‘eyes and ears’ for photonics technologies
A new Defense Department project will help researchers develop sensors for photonics-based systems with applications in environmental monitoring, disease diagnosis, and detection of chemical and biological weapons.